Economic burden of hematologic adverse events (AEs) associated with metastatic colorectal cancer (mCRC) treatment in the United States (US).
2016
e15008Background: Hematologic (HEM) AEs are common during treatment (tx) for mCRC and have been associated with a significant economic burden. This study assessed the incremental costs of HEM AEs v...
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI